Description: a-t englisch. Bestellungen. arznei-telegramm 2005; 36: 57. ANGIOGENESIS INHIBITOR BEVACIZUMAB (AVASTIN) IN COLORECTAL CARCINOMA. The anti-tumour drug bevacizumab (AVASTIN) is on the market since February 2005. CAMPTO) or with 5-FU/FA alone as first line therapy in metastatic colorectal carcinoma (1). first line therapy in metastatic colorectal carcinoma (3)which prolongs the median

Category: Colorectal Carcinoma

Url: http://www.arzneimittel-telegramm.de/journal/j_0506_a.php3

Date: Oct 7, 2005

Current Rating: 0.00

Clicks/Hits Received: 3